Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?

被引:93
作者
Kawamura, Takahiko [1 ,2 ]
Umemura, Toshitaka [3 ]
Hotta, Nigishi [1 ]
机构
[1] Chubu Rosai Hosp, Dept Diabet & Endocrine Internal Med, Nagoya, Aichi, Japan
[2] Chubu Rosai Hosp, Ctr Prevent Med, Nagoya, Aichi, Japan
[3] Chubu Rosai Hosp, Dept Neurol, Nagoya, Aichi, Japan
关键词
Cognitive function; Diabetes mellitus; Glycemic control; WHITE-MATTER HYPERINTENSITIES; SMALL-VESSEL DISEASE; SILENT CEREBRAL INFARCTION; C-REACTIVE PROTEIN; ALZHEIMER-DISEASE; SEVERE HYPOGLYCEMIA; OLDER-PEOPLE; BRAIN VOLUME; MICROVASCULAR DISEASE; INFLAMMATORY MARKERS;
D O I
10.1111/j.2040-1124.2012.00234.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is well recognized that the prevalence of dementia is higher in diabetic patients than non-diabetic subjects. The incidence of diabetes has been increasing because of dramatic changes in lifestyles, and combined with longer lifespans as a result of advances in medical technology, this has brought about an increase in the number of elderly diabetic patients. Together, aging and diabetes have contributed to dementia becoming a serious problem. Progression to dementia reduces quality of life, and imposes a burden on both patients themselves and the families supporting them. Therefore, preventing the complication of dementia will become more and more important in the future. Although many mechanisms have been considered for an association between diabetes and cognitive dysfunction, glucose metabolism abnormalities such as hyperglycemia and hypoglycemia, and insulin action abnormalities such as insulin deficiency and insulin resistance can be causes of cognitive impairment. Recent large-scale longitudinal studies have found an association between glycemic control and cognitive decline, although it is still unclear how cognitive decline might be prevented by good glycemic control. However, at an early stage, it is necessary to detect moderate cognitive dysfunction and try to reduce the risk factors for it, which should result in prevention of dementia, as well as vascular events. In the present review, in addition to outlining an association between diabetes and cognitive function, we discuss how glycemic control and cognitive decline are related.
引用
收藏
页码:413 / 423
页数:11
相关论文
共 109 条
[11]   Risk of dementia in diabetes mellitus: a systematic review [J].
Biessels, GJ ;
Staekenborg, S ;
Brunner, E ;
Brayne, C ;
Scheltens, P .
LANCET NEUROLOGY, 2006, 5 (01) :64-74
[12]   APOE genotype and cognitive decline in a middle-aged cohort [J].
Blair, CK ;
Folsom, AR ;
Knopman, DS ;
Bray, MS ;
Mosley, TH ;
Boerwinkle, E .
NEUROLOGY, 2005, 64 (02) :268-276
[13]   An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers [J].
Bomfim, Theresa R. ;
Forny-Germano, Leticia ;
Sathler, Luciana B. ;
Brito-Moreira, Jordano ;
Houzel, Jean-Christophe ;
Decker, Helena ;
Silverman, Michael A. ;
Kazi, Hala ;
Melo, Helen M. ;
McClean, Paula L. ;
Holscher, Christian ;
Arnold, Steven E. ;
Talbot, Konrad ;
Klein, William L. ;
Munoz, Douglas P. ;
Ferreira, Sergio T. ;
De Felice, Fernanda G. .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04) :1339-1353
[14]   Predictors of cognitive impairment and dementia in older people with diabetes [J].
Bruce, D. G. ;
Davis, W. A. ;
Casey, G. P. ;
Starkstein, S. E. ;
Clarnette, R. M. ;
Foster, J. K. ;
Almeida, O. P. ;
Davis, T. M. E. .
DIABETOLOGIA, 2008, 51 (02) :241-248
[15]   Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study [J].
Bruce, D. G. ;
Davis, W. A. ;
Casey, G. P. ;
Clarnette, R. M. ;
Brown, S. G. A. ;
Jacobs, I. G. ;
Almeida, O. P. ;
Davis, T. M. E. .
DIABETOLOGIA, 2009, 52 (09) :1808-1815
[16]   Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study [J].
Christman, A. L. ;
Matsushita, K. ;
Gottesman, R. F. ;
Mosley, T. ;
Alonso, A. ;
Coresh, J. ;
Hill-Briggs, F. ;
Sharrett, A. R. ;
Selvin, E. .
DIABETOLOGIA, 2011, 54 (07) :1645-1652
[17]   Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation [J].
Craft, S .
NEUROBIOLOGY OF AGING, 2005, 26 :S65-S69
[18]   Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial [J].
Craft, Suzanne ;
Baker, Laura D. ;
Montine, Thomas J. ;
Minoshima, Satoshi ;
Watson, G. Stennis ;
Claxton, Amy ;
Arbuckle, Matthew ;
Callaghan, Maureen ;
Tsai, Elaine ;
Plymate, Stephen R. ;
Green, Pattie S. ;
Leverenz, James ;
Cross, Donna ;
Gerton, Brooke .
ARCHIVES OF NEUROLOGY, 2012, 69 (01) :29-38
[19]   Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies [J].
Cukierman, T ;
Gerstein, HC ;
Williamson, JD .
DIABETOLOGIA, 2005, 48 (12) :2460-2469
[20]   Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial [J].
Cukierman-Yaffe, Tali ;
Gerstein, Hertzel C. ;
Williamson, Jeff D. ;
Lazar, Ronald M. ;
Lovato, Laura ;
Miller, Michael E. ;
Coker, Laura H. ;
Murray, Anne ;
Sullivan, Mark D. ;
Marcovina, Santica M. ;
Launer, Lenore J. .
DIABETES CARE, 2009, 32 (02) :221-226